Corcept Therapeutics Incorporated
CORT
Classifica tra le azioni
#1757
Corcept Therapeutics Incorporated, founded in 1998 and headquartered in Menlo... Corcept Therapeutics Incorporated, founded in 1998 and headquartered in Menlo Park, California, is a pharmaceutical firm dedicated to the discovery, development, and commercialization of treatments for serious metabolic, oncological, and neuropsychiatric disorders across the United States. Its primary commercial offering is Korlym (mifepristone) tablets, an oral medication taken once daily. Korlym is prescribed for adult patients diagnosed with endogenous Cushing's syndrome who suffer from hyperglycemia due to hypercortisolism, particularly those with type 2 diabetes or glucose intolerance, and for whom surgical options have either failed or are not viable. The company's development pipeline is robust, featuring relacorilant, which is being advanced for Cushing's syndrome. It is also investigating a combination of relacorilant with nab-paclitaxel; this pairing has concluded Phase II clinical trials for advanced ovarian tumors and is additionally being studied for conditions involving cortisol excess. Furthermore, Corcept is developing distinct selective cortisol modulators for specific indications such as metastatic castration-resistant prostate cancer and antipsychotic-induced weight gain, alongside research into FKBP5 gene expression assays.
Prezzo delle azioni
$112.72
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$12.18B
Variazione (1 giorno)
2.32%
Variazione (1 anno)
43.41%
Paese
US
Scambia Corcept Therapeutics Incorporated (CORT)
Categoria
Healthcare
Numero di azioni in circolazione per Corcept Therapeutics Incorporated (CORT)
Numero di azioni in circolazione al June 2026: 105.38M
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Corcept Therapeutics Incorporated, il numero attuale di azioni in circolazione è 105.38M. Alla fine del December 2023, la società aveva 103.56M azioni in circolazione. Il numero di azioni in circolazione è solitamente influenzato da split azionari e riacquisti.
Storico delle azioni in circolazione di Corcept Therapeutics Incorporated (CORT) dal 2001 al 2026
Azioni in circolazione alla fine di ogni anno
| Anno | Azioni in circolazione | Cambia |
|---|---|---|
| 2026 (TTM) | 105.38M | 2.08% |
| 2024 | 103.23M | -0.32% |
| 2023 | 103.56M | -3.02% |
| 2022 | 106.79M | -7.67% |
| 2021 | 115.65M | 0.21% |
| 2020 | 115.41M | 0.93% |
| 2019 | 114.35M | -9.02% |
| 2018 | 125.68M | 10.71% |
| 2017 | 113.53M | 2.68% |
| 2016 | 110.57M | 3.53% |
| 2015 | 106.80M | 5.77% |
| 2014 | 100.98M | 1.16% |
| 2013 | 99.82M | 7.31% |
| 2012 | 93.02M | 11.65% |
| 2011 | 83.31M | 21.91% |
| 2010 | 68.34M | 30.31% |
| 2009 | 52.44M | 12.25% |
| 2008 | 46.72M | 36.41% |
| 2007 | 34.25M | 49.95% |
| 2006 | 22.84M | 1.03% |
| 2005 | 22.61M | 22.60% |
| 2004 | 18.44M | 113.17% |
| 2003 | 8.65M | 28.73% |
| 2002 | 6.72M | 25.00% |
| 2001 | 5.38M | 0.00% |
Azioni in circolazione per aziende simili o concorrenti
| Azienda | Azioni in circolazione | Differenza | Il paese |
|---|---|---|---|
| 445.06M | 322.35% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| 18.05B | 17,027.57% |
HK
|
